GlassScriptPhysician profile
Elizabeth Palmer
NPI 1588822050
$8,610.36
in general payments reported to CMS, 2019-2025
50 companies · $1,260 in 2025
The $1,260 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,989 · 2020: $268 · 2021: $952 · 2022: $1,269 · 2023: $1,270 · 2024: $1,602 · 2025: $1,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,132.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,160.96 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $990.33 | 2019-2025 | |
| Pfizer INC. | $631.93 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $607.22 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $541.96 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $480.18 | 2019-2025 | Repatha, Otezla, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $403.79 | 2019-2024 | Trintellix |
| Novartis Pharmaceuticals Corporation | $397.05 | 2020-2025 | |
| Glaxosmithkline, LLC. | $344.08 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $263.28 | 2022-2025 | |
| Amarin Pharma, INC. | $210.40 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $205.75 | 2019-2025 | Xifaxan |
| Axsome Therapeutics, INC. | $193.68 | 2023-2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $167.10 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $154.67 | 2022-2025 | Eliquis, Camzyos |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.